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This paper describes the use of diverse software tools in cardiovascular applications. These
tools were primarily developed in the ﬁeld of engineering and the applications presented
push the boundaries of the software to address events related to venous and arterial
valve closure, exploration of dynamic boundary conditions or the inclusion of multi-scale
boundary conditions from protein to organ levels. The future of cardiovascular research and
the challenges that modellers and clinicians face from validation to clinical uptake are
discussed from an end-user perspective.
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1. The predictive paradigm for the treatment of
cardiovascular disease
Clinicians use a number of different tests to determine the nature of a medical
condition and then plan a treatment/intervention based upon experience.
Success may be deﬁned in a number of ways depending on the nature of the
treatment; it may be the ability to regain certain bodily functions, or to increase
life expectancy. The range of inter-patient variability, particularly when disease
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ment and a reliance on statistical methods based on average behaviour can result
in poor predictive power for individual patients.
It is interesting to compare medical practice with engineering. Both disciplines
are based on problem solving. In engineering, there is an attempt to predict
accurately the performance of a product or procedure. The entire design process
is based upon predicted outcomes. Very often a number of criteria must be
satisﬁed simultaneously and sophisticated computer and analysis technologies
are employed to accomplish this. By contrast, owing to the complexity and
inherent variability of the underlying biological behaviour, medicine has tended
to adopt a semi-empirical approach, with observations from clinical studies
interpreted in combination with detailed in vitro analysis of individual
components of the system. An exciting option that is currently being
investigated is the possibility of combining these two different approaches.
Recent advances in information and communication technology have enabled
predictive engineering methodologies to be integrated within the medical
environment. A future can be envisaged where technology is adapted to
individual patients, with appropriate treatment conceived to suit a set of
speciﬁc and unique needs. This integrative vision of human physiology, in
combination with the advances in computational modelling and simulation, will
help unravel the systemic nature governing many of the physical manifestations
of disease.
Cardiovascular engineering is one of the success stories in bioengineering. The
application of mathematical modelling in cardiovascular physiology gained
prominence in the 1950s with Hodgkin and Huxley’s successful prediction of the
speed of action potential propagation along a nerve ﬁbre from cable theory,
coupled to models of ion channel conduction and gating kinetics (Hodgkin &
Huxley 1952; Noble 1962). Other early successes in applying techniques taken
from the physical sciences to cardiovascular physiology were engineering
analyses of blood ﬂow in arteries using computational ﬂuid dynamics (CFD).
These were later coupled with ﬁnite-element (FE) analyses to model the
structural behaviour of tissue. Until fairly recently, simulation of arterial blood
ﬂow involved the use of very simple, idealized models and the relevance to
medical practice was very limited. More realistic representations of the arterial
system (Jones et al. 2004a,b) that can be used to simulate pre-operative, diseased
conﬁgurations and to analyse post-operative outcomes are now employed
(Migliavacca et al. 2005). ‘Predictive medicine’ in which patient-speciﬁc
computer models are used to evaluate the efﬁcacy of a number of possible
treatments and to plan and design the optimal intervention based on outcome
prediction is now a possibility. It is clear that, with current technology and
sufﬁcient effort, the immediate consequences of an intervention might be
predicted. The effectiveness of a bypass graft conﬁguration can be assessed with
reference to the redistribution of blood ﬂow, for example. Of even greater
importance is the prediction of the implications of intervention after time has
elapsed: one month; three months; six months; one year; two years; or more.
Two speciﬁc examples of cardiovascular engineering applications are the study
of coronary stent implantation and the design analysis of prosthetic heart valves.
Stents are devices that re-establish and maintain the patency of an artery after
development of atherosclerotic plaque and narrowing of the vessel lumen.
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abnormal cell proliferation within the vessel wall leading to intimal thickening,
restenosis and thrombus formation. In non-technical terms, the artery recloses,
restricting blood ﬂow. These phenomena involve chemical and cellular responses
to mechanical stimuli, such as strain in the vessel wall and wall shear stress
induced by the intervention and redistribution of blood ﬂow. The exciting
prospect is that these can be represented mathematically; researchers are
beginning to develop models of these phenomena. Growth and adaptation models
are envisioned not only for the response of biological tissues to external
intervention but, additionally, for the evolution of the disease process, in this
case, restenosis (Evans et al. 2008).
Research related to valve replacement and repair is of signiﬁcant clinical
interest. While existing mechanical heart valves (MHVs) and biological valves
(BVs) are used routinely, there are still important issues to solve regarding the
inherent thrombogenecity of MHVs and the durability of BVs. In addition, new
endovascular techniques for percutaneous heart valve implantation are being
developed to avoid open heart surgery (Bonhoeffer et al. 2000) and the design
and implementation of these devices is in an on-going developmental phase.
There is a clear role for modelling and simulation in the study of both existing
and novel devices, and signiﬁcant work related to the assessment and behaviour
of these valves under patient-speciﬁc conditions and with reference to
pharmacological intervention remains to be carried out.
Ultimately, a holistic representation encompassing the complex interactions
between the heart, vasculature and the systemic response to the changing
physiological environment is needed. This requires patient-speciﬁc models of the
heart to consider all the integrated elements of the system. Impressive and
detailed models of the heart have been developed already (Hunter et al. 2001)
but, due to their signiﬁcant computational requirements, they are not as yet
applicable in the context of the rapid or real-time simulation that is often
demanded for diagnostic purposes. There remains a place for simpler
representations of the fundamental mechanisms describing the heart beyond
the ‘elastance’ model, well known to cardiovascular scientists, which became a
paradigm in cardiovascular engineering. With regards to the elastance concept,
while engineers and physicists tried to explain cardiovascular function in
mathematical terms that had little meaning to the ordinary physiologist, a real
scientiﬁc revolution took place in a totally different arena. Ideas and techniques
developed for studying the molecular foundations of physiology captured the
imagination of cardiovascular scientists. Within this new framework, multi-scale
and multi-physics modelling approaches seem to be the way forwards but the
future remains open in this area.
In this paper, we present the application of a number of diverse software tools
in cardiovascular modelling and simulation from the end-user’s perspective.
While these tools essentially belong to the ﬁeld of engineering, the applications
presented push the boundaries of the available software to address speciﬁc events
related to venous and arterial valve closure, the exploration of dynamic
boundary conditions or the inclusion of multi-scale boundary conditions from
the level of the protein to the organ.
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development and methodologies
The key to successful computational physiology is the capture of structure–
function relationships in a computationally efﬁcient manner. This approach
requires models that are fundamentally different from those in the world of
engineering (Crampin et al. 2003). Development of multi-scale models that take
into account the underlying biological mechanisms and interface local three-
dimensional models with systemic models has the potential to improve
substantially the current simulation framework based on established software
packages. Owing to their complexity, the behaviour of such models is normally
studied in isolation. This is far from representative of the physiological situation.
One solution is to provide boundary conditions and an appropriate environment
with the same detail as the model itself. This issue raises a number of questions:
is this level of complexity and its associated computational overhead necessary;
do we need highly detailed models of the environment in order to reproduce, or
understand, the behaviour of a system; and is this currently possible in terms of
computational effort?
(a) Quantitative versus qualitative results
The question of a qualitative versus a quantitative approach is at the core of
the diagnosis paradigm. Although it is generally understood that medicine is
far from an exact science, it is still necessary to obtain quantitative data within
a certain level of accuracy in order to provide reliable tools for diagnosis.
Diagnosis is based on knowledge extracted from a multitude of sources, including
quantitative tools, although there are many subjective factors in play.
Knowledge gained can be inﬂuenced by context and the interaction between
the doctor and the patient. Qualitative results are often useful to help
interpret quantitative ﬁndings as they are extremely important for under-
standing ‘why’ questions.
Quantiﬁcation is often difﬁcult as there is signiﬁcant variability from patient
to patient, prompting a population-based approach. When applied to medicine,
physical ﬁndings which attempt to answer ‘why’ questions must have individual
relevance, as diagnosis must be made on an individual basis taking into account
speciﬁc patient characteristics. It becomes evident that for precise results, we will
need detailed quantitative models. This point is crucial. Not only do we need
sophisticated tools that are reliable from a numerical point of view, but we also
need adaptable tools able to cope with multi-physics and multi-scale problems
ranging from molecular to physiological levels. This increasing level of
complexity generates a cost, in terms of computational resources, that is
unavailable to many researchers. In-house tools must be developed, maintained
and updated, or the cardiovascular scientist must rely on commercial software,
adapting it to speciﬁc needs. In §2b, we present models employing customized
software, for diverse applications. In many cases, this required close interaction
between researchers and software developers. The role of boundary conditions is
also discussed.
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(i) Development of ﬂuid–structure interaction tools, the Bloodsim project
and applications
Many cardiovascular problems involve signiﬁcant interaction between ﬂuid
(primarily blood) and solid (blood vessel walls, heart valve leaﬂets) components.
With advances in computational hardware, numerical solution of ﬂuid–structure
interaction (FSI) has recently become achievable and applied to cardiovascular
problems (Krafczyk et al. 2001; De Hart et al. 2003; Grifﬁth et al. 2007). Between
1998 and 2001, the Bloodsim project developed tools to provide an external
coupling between the commercial solvers ANSYS (structural, FE) and CFX
(ﬂuid, ﬁnite volume) to solve such problems. Successful implementation of the
coupling scheme was achieved through the inclusion of CFX as a partner within
the project consortium, allowing access to the code at a low level and providing
signiﬁcant solver development experience. (It is of interest to note that, following
acquisition of CFX by ANSYS in 2003, a similar approach to coupling between
the two codes was implemented as an ‘out-of-the-box’ feature of the ANSYS
multi-ﬁeld analysis option.) An attraction of coupling existing mature solvers is
that they contain optimized specialized features, including nonlinear structural
materials, large deformations, contact and advanced ﬂuid models. Applications
of the Bloodsim FSI code included an examination of ﬂow local to a stent
geometry deployed within a uniform elastic tube (Hose et al. 2003). This analysis
included contact of the stent with the tube wall during deployment, resulting in a
complex internal ﬂuid domain. The Bloodsim approach was also applied to the
analysis of forces acting on a prosthetic heart valve at closure (Hose et al. 2006).
In this example, the rigid body solution of the coupling scheme was employed.
When considering mechanical valves, it is advantageous to neglect the structural
response of the valve leaﬂet and consider it as a rigid body. This allows the
fundamental dynamics of leaﬂet motion and the forces due to sudden arrest of
the local ﬂuid at closure to be determined without the solution of the full
structural response. Coupling is still required between the calculated rigid body
motion and the update of the ﬂuid mesh geometry and local ﬂuid forces.
(ii) Simulation of natural valves and investigation of deep vein thrombosis
The use of independent solvers that iteratively pass interface values of either
displacement or pressure ﬁelds to achieve a coupled solution has been shown to
be effective for a range of problems. However, for highly ﬂexible structures, it is
often difﬁcult to obtain a stable response using such schemes, a particular
example being native cardiac valves. With the exception of a recent lattice–
Boltzmann simulation (Buxton & Clarke 2006), little attention has been paid to
the valves in the venous system. Given the potential involvement of venous valve
haemodynamics in the development of deep vein thrombosis (Malone & Agutter
2006), this is an area that warrants more detailed investigation.
A three-dimensional venous valve model using the commercial code
LS-DYNA (v. 971) was developed. LS-DYNA is an explicit FE program used
in the analysis of nonlinear dynamic responses of three-dimensional structures.
A particular attraction, and the reason for its selection for simulating venous
valves, is the relative stability of its approach to ﬂuid–solid interaction when
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The model geometry is shown in ﬁgure 1. This implementation requires
additional ﬂuid elements to be deﬁned external to the vessel, allowing ﬂuid to
move into these elements as the solution progresses.
For this application, the model geometry was generated using ANSYS classic.
Ansys Parametric Design Language was then used to output the model geometry
in a format that could be directly imported into the Primer pre-processor
(Ove/Arup).Once boundaryconditions were applied, the model wassolved within
LS-DYNAandtheresultsinterpretedusingthed3plotpost-processor(Ove/Arup).
ENSIGHT v. 8.2 (CEI) software was used for extended visualization facilities,
movie creation, image capturing and particle tracking. The latter was
particularly appropriate for this application, allowing the development of
methods to quantify the ‘washout’ of blood particles in the regions of interest,
as shown in ﬁgure 1. A primary aim was to determine the effects of gravitational
loading on valve haemodynamics; the results showed that the application of
gravity helps to move blood from regions of stasis. Validation of the method was
obtained by comparing the results of the three-dimensional model with
theoretical solutions and with the results obtained from published one-
dimensional models (Zervides 2008; Zervides et al. 2008a,b). The potential of
these models is enormous. Further applications include patient-speciﬁc
simulations to examine the effect of compression therapies and pharmacological
prophylaxis and the development of prosthetic venous valve implants.
(iii) A detailed representation of the arterial system for patient-speciﬁc
simulations
If it were possible to simulate the entire human body, one could envisage a
completely closed ﬂuid model, including the heart, arteries, capillaries and veins.
However, to model this as a single three-dimensional model is impractical. The
patient scan data required to obtain the geometry is often conﬁned to a
particular region of the body. Thus, at some point, the ﬂuid model must be
truncated to give inlets and outlets where boundary conditions must be speciﬁed.
In the simplest case, ﬂow rates or pressures are imposed directly at the
boundaries. Alternatively, a simpliﬁed representation of the remainder of
the circulatory system can be coupled to the boundaries. This reduced model
would typically be based upon standardized data from the general population
rather than being for a speciﬁc patient. At its least complex, the model could be
venous valve
venous wall
g
(a)( b)
Figure 1. (a) The ﬂuid was represented using eight-node solid nodes and the vein wall and venous
valve were represented by four-node shell elements (LS-DYNA model of vein and valve). The
direction of gravityisindicated. (b) Flow was establishedusinga parabolicinlet condition representing
the input ﬂow of the femoral vein and a zero output pressure condition to allow unimpeded ﬂow
through the valve (seeded particles illustrating evolution ofﬂow local to valve structure).
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together models of differing complexity has been considered by Formaggia et al.
(2001) coupling a three-dimensional ﬂuid model with a solid model wall to a
nonlinear one-dimensional model at the outlet. This was found to be an effective
way of reducing spurious wave reﬂections at the outlet boundary of the
three-dimensional model. The coupling of a three-dimensional model to a zero-
dimensional compartment model, using state variables to describe the
compartment model, has been analysed by Quarteroni & Veneziani (2003).
This approach in the clinical application of paediatric cardiac surgery is used
by Migliavacca et al. (2005). A scheme for coupling a three-dimensional model
to a digital implementation of the Westerhof model (in both frequency and
time domains; Westerhof et al. 1969) has been implemented. The frequency
domain analysis simply involves adding up complex impedances in series or
parallel until the ‘root impedance’ of the whole branching tree is determined at
the desired frequency. One method of obtaining the time domain response would
be to perform an inverse Fourier transform of the frequency response. However,
this approach is applicable only to repetitive signals, and does not easily lend
itself to determination of the pressures and ﬂows throughout the model. Instead,
a model of the Westerhof circuit using a state-space approach was created.
The results of a simulation of this type are shown in ﬁgure 2.
For patient-speciﬁcsimulation, it isimportant that simulations canbeperformed
onaroutinebasisintheclinicalsetting.Inthiscontext,theuserinteractionrequired
to create the CFD model must be minimized, automating the mesh generation
process as far as possible. Furthermore, the high-performance computing (HPC)
required for transient CFD simulation must be accessible, possibly using grid
technology (Jones et al. 2004a,b).
(iv) Three-dimensional simulation with biologically oriented boundary
conditions: the C-CARES project
Section 2b(iii) illustrates the realistic representations of the arterial tree
for patient-speciﬁc simulations (Jones et al. 2004a,b) describing appropriate
boundary conditions for the afterload, using patient-speciﬁc data (length of
vessels, diameter, etc.). However, the cardiovascular system is a coupled heart–
arterial network system, and thus both the pumping and load systems must be
described correctly. Dynamic boundary conditions, described in terms of
pressure and ﬂow, are certainly better than imposed input and output conditions
from a haemodynamic point of view. This section illustrates how this idea was
developed further. A coupled system of a St Jude MHV and biologically based
boundary conditions of the pumping system is presented (Raﬁroiu et al. 2008),
taking into account fundamental biochemical details of cardiac contraction. This
kind of approach, which has already been presented in the context of an idealized
valve (Dı ´az-Zuccarini et al. 2007), can provide insight into the underlying
biological mechanisms of contraction at different levels, from the protein to the
organ. A multi-physics and multi-scale lumped-parameter model of the left
ventricle was used as a boundary condition for a three-dimensional model of a
St Jude valve in mitral position and was implemented in CFX by developing
speciﬁc Fortran subroutines, making use of advanced user tools such as junction
boxes and subroutines within the CFX software (Dı ´az-Zuccarini et al. 2008).
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of the design around the hinges was captured. The geometry was imported into
ANSYS WORKBENCH and the FSI simulation performed using CFX v. 10.0.
Collaboration with the software developers was required to develop semi-
automatic remeshing tools, taking advantage of meshing interpolation techniques
and the ANSYS WORKBENCH–CFX interface. The extent to which these
simulations can be parallelized remains to be investigated and it certainly
represents a challenge. One possible application of this methodology is the
exploration of the effect of pharmacological intervention on the behaviour of
medical devices and implants. This is a key issue since patients undergoing this
type of surgery normally receive medication for life; information could be
provided on possible outcomes and alternative treatments.
(v) Design of percutaneous heart valves and the relevance of anatomical data for
patient-speciﬁc purposes
Valve replacement by percutaneous transcatheter implantation is a novel
procedure that allows a prosthetic valve to be implanted by delivering the valve
in a stent into the aorta via a catheter inserted through an artery in the
groin. This technique eliminates some of the risk associated with conventional
surgery, providing an alternative treatment for patients currently excluded
flow
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Figure 2. (a) The inlet ﬂow to the aorta model was speciﬁed using data from a ﬂow-sensitive fast-
ﬁeld magnetic resonance echo sequence acquired in the same session as the anatomical scan. The
outlets of the model were coupled to linear compartmental models that represent the downstream
circulatory system (three-dimensional mesh coupled to downstream compartments). (b) CFD
simulation of the three-dimensional aorta model is performed using CFX. Reference mesh coupled
to the compartment models and results for the three-dimensional model and compartment systems
(three-dimensional ﬂow solution at peak systolic ﬂow). (c) The solution of the compartment models
allows the pressure and ﬂow at downstream locations in the circulatory system to be determined
(compartment solution at peak systolic ﬂow). Also, the compartment models provide improved
boundary conditions for the three-dimensional model.
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this approach indicate that the technique is both feasible and promising
(Ghanbari et al. 2008).
Numerical simulation of percutaneous valves is challenging. The valve has to be
collapsed to a small diameter for catheter delivery and then expanded
to the operative conﬁguration within the aorta. Modelling this process
requires large deformations of highly nonlinear materials, for both balloon-
expandable stents and self-expanding hyperelastic stents. The valve component is
typically manufactured from a biological soft tissue or hyperelastic polymer, and
all the difﬁculties mentioned in the context of simulation of natural valves apply.
The implicit commercial package MSC.MARC was chosen to perform the
simulation of both crimping and releasing of the valve. This code is efﬁcient
when dealing with nonlinearities, including severe contact problems. Moreover, it
contains a set of material models suitable for describing the mechanical and
thermo-mechanical behaviour of superelastic and memory-shape alloys such as
nitinol, commonly used in self-expanding valves (Auricchio et al. 1997). The effect
of blood ﬂow during valve release required FSI analyses with LS-DYNA.
We envisage that numerical simulation, especially patient-speciﬁc and
predictive modelling, will have an increasingly important role in the development
of percutaneous valves, since functional performance is strongly dependent on the
speciﬁc anatomyof thepatientandontheirmaterialproperties.It isessential to be
able to ensure that the minimal valve requirements are guaranteed for a speciﬁc
patient, andcanbe maintainedfora sufﬁcienttime as nativestructures changedue
to age-related physiological modiﬁcation or as a response to the treatment.
3. Current limitations and future challenges
There are three primary issues. First, this approach is computationally intensive,
pushing the boundaries of what can be achieved with commercial software. From a
numerical point of view, the multi-scale nature of the applications, and time-
varying and nonlinear characteristics of the boundary conditions, in combination
withthecouplingmethodologiesanddiscretizationtechniquesusedtodeﬁnethem,
often requires small time steps to achieve convergence. This issue could prove
critical as thesimulationof long physicaltime scalesis constrainedby theextent of
the physical domain, mesh reﬁnement requirements and ﬂuid behaviour, among
other things. HPC simulation, possibly using grid technology, must be accessible.
Second, a conceptual problem arises in understanding the biology behind the
problem and extracting the most relevant information to deﬁne and implement
the computational models. This is particularly relevant to patient-speciﬁc
modelling in the context of routine simulation in a clinical environment.
A comprehensive set of parameters for the ‘patient-speciﬁc’ model must be
deﬁned at different physical and biological scales and account must be taken of
individual inter-variability and ageing processes. A question then must be asked:
what is patient-speciﬁc modelling and in which context? This is intimately linked
to clinical uptake as discussed brieﬂy below. Several related problems now emerge.
The biological mechanisms of different processes need to be understood separately,
each described in different terms and relevant parameters and mechanisms
identiﬁed. These models then have to be translated mathematically using
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biologically and physically relevant and coherent. This ﬂexibility must be taken
into account by software developers and a joint effort is required to develop
computational frameworks for multi-science and multi-scale simulation. Recent
initiatives (Evans et al. 2008) propose a structured way to deal with these
problems. These approaches must start to be incorporated in commercial software
applications to reach the simulation community at large. Such tools must allow
integration of data ranging from the molecular level (spatial scale: 10
K9 m; time
scale: 10
K6 s) to the organism (spatial scale: 10
0 m; time scale: 10
9 s) level (Fenner
et al. 2008) and, in combination with the existing grid infrastructure and other
HPC platforms, to apply this understanding to the clinic. A multi-scale modelling
framework could provide a more rational basis for diagnosis and treatment than
currently exists. It is not obvious how to achieve continuity in models and
simulations across biological levels, each of which is normally governed by speciﬁc
rules and assumptions (DG INFSO & DG JRC 2005).
Last but not least, there is a long journey between simulation and treatment.
Clinical factors such as the severity of the disease, availability of treatment, and
effectiveness and accessibility of screening and surveillance methods will inﬂuence
clinical uptake. Technical accuracy (analytic validity); predictive power (clinical
validity); potential for improving healthcare and health outcomes (clinical usage);
and ethical, legal and social implications (Shah 2004) will all be important.
Clinical applications will have to meet rigid constraints. As recent initiatives, such
as the VPH, have placed a strong emphasis on industrial and clinical applications,
these are some of the challenges that such initiatives will certainly confront.
4. Conclusions: the future of cardiovascular research
There are lessons embedded in the history of cardiovascular physiology. We need
to update the deﬁnition of physiology to include computational physiology as an
integral part of the process. There is a strong need for specialist understanding of
the behaviour of the parts as these are required to illuminate the behaviour of the
whole. But this process is bidirectional. A complete understanding of
cardiovascular function requires input from biophysics, biochemistry, pharma-
cology, structural biology, genetics, bioengineering, mathematics and other ﬁelds.
Improving fundamental understanding is a common goal that is rarely achieved at
present. We need to put this integrated knowledge within a context, which is
provided by systems biology. The current discipline-based organization of the
biomedical, engineering and physical sciences is inconsistent with a revolution in
biology that has provided a common conceptual foundation now shared by all
disciplines, as evidenced by the current proliferation of multidisciplinary faculties
and institutes. We must also train university students to develop a broad view of
cardiovascular science that spans from molecular biology to computational
physiology with an integration of human biology as a whole. An effort will be
needed at the academic level to break down the barriers created by the traditional
disciplinary approaches. We also need to take research out of academic circles and
to translate cardiovascular engineering into clinical applications, with patient-
speciﬁc treatment as the ultimate long-term goal. Finally, we need greater
integration with software developers to guide the development of speciﬁc tools to
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engineer to take on a role that focuses on the modelling, simulation and analysis of
cardiovascular disease. Computational physiology has been identiﬁed by Sun and
competitors as the ‘next big thing’ (Malcolm 2003); thus we could argue quite
conﬁdently that an increasing market for these complex software applications is
about to explode. This synergy will certainly facilitate the translation of basic
research into clinical strategies for care of patients with cardiovascular disease.
With necessity as a driving force, a multi-scale approach from the molecular and
cellular level up to the organ and system levels is emerging. The solution to this
problem is far from simple and will certainly require input from mathematicians,
physicists, computer scientists, engineers and biologists.
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